SNC-Lavalin Group Inc
F:LAV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SNC-Lavalin Group Inc
F:LAV
|
CA |
|
Century Therapeutics Inc
NASDAQ:IPSC
|
US |
|
PCC Exol SA
F:9B2
|
PL |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LAV's stock price target?
Not Available
LAV does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for SNC-Lavalin Group Inc?
Projected CAGR
-11%
Over the last 8 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 2 years is -11%.
What is the Net Income forecast for SNC-Lavalin Group Inc?
Projected CAGR
393%
Over the last 8 years, the compound annual growth rate for Net Income has been -46%. The projected CAGR for the next 2 years is 393%.